Sally Eid Khaled

Dr. Sally Eid Khaled

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
Mohamed FaragMohamed Farag
Mohamed Farag
SKSally Eid Khaled
Sally Eid Khaled
ZGZeina El Gingeehy
Zeina El Gingeehy
SSSamir Nabhan Shamma
Samir Nabhan Shamma
Ahmed ZayedAhmed Zayed
Ahmed Zayed
Various species of cinnamon (Cinnamomum sp.) are consumed as traditional medicine and popular spice worldwide. The current research aimed to provide the first comparative metabolomics study in nine cinnamon drugs and their different commercial preparations based on three analytical platforms, i.e., solid-phase microextraction coupled to gas chromatography–mass spectrometry method (SPME/GC–MS), nuclear magnetic resonance (NMR), and ultraviolet-visible spectrophotometry (UV/Vis) targeting its metabolome. SPME/GC–MS of cinnamon aroma compounds showed a total of 126 peaks, where (E)-cinnamaldehyde was the major volatile detected at 4.2–60.9% and 6.3–64.5% in authenticated and commercial preparations, respectively. Asides, modeling of the GC/MS dataset could relate the commercial products CP-1 and CP-3 to C. cassia attributed to their higher coumarin and low (E)-cinnamaldehyde content. In contrast, NMR fingerprinting identified (E)-methoxy cinnamaldehyde and coumarin as alternative markers for C. verum and C. iners, respectively. Additionally, quantitative NMR (qNMR) standardized cinnamon extracts based on major metabolites. UV/Vis showed to be of low discrimination power, but its orthogonal projections to latent structures discriminant analysis (OPLS-DA) S-plot showed that C. iners was more abundant in cinnamic acid compared to other samples. Results of this study provide potential insights into cinnamon drugs QC analysis and identify alternative markers for their discrimination.

17 June 2019 in Food & Function
Verified
Journal Article
Closed access
PDF file
SKSally Eid Khaled
Sally Eid Khaled
FHFatma A.-M. Hashem
Fatma A.-M. Hashem
MSManal H. Shabana
Manal H. Shabana
AHAbdel-Mohsen M. Hammam
Abdel-Mohsen M. Hammam
AMAbdel Nasser A. Madboli
Abdel Nasser A. Madboli
Mohamed FaragMohamed Farag
Mohamed Farag
Phyllanthus emblica L. fruits have long been used in Ayurvedic medicine for their many health benefits. In this study, we present P. emblica fruit crude extract and fractions’ effects on the female reproductive system by assessing its estrogenic and gonadotropic activities. Results revealed that the non-polar petroleum ether and chloroform fractions exhibited the strongest estrogenic and follicle-stimulating hormone-like [FSH] activity, while the n-butanol fraction exhibited a significant luteinizing hormone-like [LH] activity. The ethyl acetate fraction showed neither estrogenic nor gonadotropic activities and in contrast it may impair female fertility suggesting that different metabolite classes contribute to the plant's overall effect on female fertility. To pinpoint active agents in these fractions, UPLC/ESI-qTOF-MS- was employed for secondary metabolite profiling with 100 metabolites annotated including ellagitannins, gallic acid derivatives, terpeneoids, sterols, phthalates and fatty acids. Correlation between extracts/fraction bioassays and UPLC/MS data was attempted using orthogonal partial least squares-discriminant analysis (OPLS-DA) revealing that guaiane-type sesquiterpenes, phthalates, diterpenes and oxygenated fatty acids showed positive correlation with estrogenic and gonadotropic activities. In contrast, mucic acid gallates, gallic acid derivatives and ellagitannins correlated negatively. GC/MS analysis of the non-polar bioactive fractions viz. petroleum ether and chloroform was also attempted which revealed its enrichment in fatty acids/fatty acyl esters (34%) and phenolic compounds (19.6%). This study provides the first report on the estrogenic and gonadotropic activities of P. emblica fruits in relation to their metabolite fingerprint.

1 December 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SKSally Eid Khaled
Sally Eid Khaled
FHFatma A.-M Hashem
Fatma A.-M Hashem
MSManal H. Shabana
Manal H. Shabana
AHAbdel-Mohsen M. Hammam
Abdel-Mohsen M. Hammam
AMAbd El-Nasser Madboli
Abd El-Nasser Madboli
DADalia AlMahdy
Dalia AlMahdy

27 September 2024 in Biocatalysis and Agricultural Biotechnology
Verified
Journal Article
Closed access
SKSally Eid Khaled
Sally Eid Khaled
FIFaten Ibrahim
Faten Ibrahim
EAEman Abdelsalam
Eman Abdelsalam
KAKawkab A. Ahmed
Kawkab A. Ahmed
AAAsmaa K Al-Mokaddem
Asmaa K Al-Mokaddem
RMReda Sayed Mohammed
Reda Sayed Mohammed

29 March 2025 in Inflammopharmacology
Verified
Journal Article
Open access
PDF file
HEHebatollah E. Eitah
Hebatollah E. Eitah
SKSally Eid Khaled
Sally Eid Khaled
EAEnaam M. AbouZeid
Enaam M. AbouZeid
RERiham A. El-Shiekh
Riham A. El-Shiekh
Wesam Taher AlmagharbehWesam Taher Almagharbeh
Wesam Taher Almagharbeh
NMNoha Mohsen Mohsen
Noha Mohsen Mohsen
Hypertrichosis and hirsutism are two distinct conditions characterized by abnormal hair growth, but they differ significantly in their underlying mechanisms and implications for patient care. Hypertrichosis, which is characterized by increased hair growth in non-androgen-dependent locations, does not require hormone level monitoring, whereas hirsutism, which is characterized by increased hair growth in androgen-dependent parts of the female genitals, requires. Hirsutism is relatively common among women. Depending on societal and ethnic standards, it might cause severe mental suffering. Importantly, hirsutism may be linked to underlying conditions and co-morbidities. Hirsutism should not be viewed solely as a cosmetic concern. Patients require appropriate examination to identify and manage underlying causes and associated consequences. The article emphasizes the need for comprehensive assessment strategies for both hypertrichosis and hirsutism. While hypertrichosis may primarily be an aesthetic concern, hirsutism requires careful evaluation due to its potential links with significant health issues. However, drugs used to treat hirsutism can cause adverse effects ranging from minor symptoms like nausea and headaches to more significant consequences like vascular clots, heart attacks, hepatotoxicity, osteoporosis, and effeminization of a male fetus. As a result, the purpose of this study is to look at the possible benefits of medicinal plants as a supplemental treatment for hirsutism, specifically whether they can be employed as adjuvants to cosmetic procedures.